id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-2537-0141,FDA,FDA-2015-D-2537,PCPC Additional Comments,Other,Background Material,2017-12-06T05:00:00Z,2017,12,2017-12-06T05:00:00Z,,2017-12-06T13:29:24Z,,0,0,0900006482ce9273
FDA-2015-D-2537-0140,FDA,FDA-2015-D-2537,ISPE Additional Comments,Other,Letter(s),2017-11-03T04:00:00Z,2017,11,2017-11-03T04:00:00Z,,2017-11-03T16:58:11Z,,0,0,0900006482c3fce8
FDA-2015-D-2537-0109,FDA,FDA-2015-D-2537,"Submission of Quality Metrics Data; Revised Draft Guidance for Industry;
Extension of Comment Period",Notice,Extension of Comment Period,2017-01-09T05:00:00Z,2017,1,2017-01-09T05:00:00Z,2017-03-28T03:59:59Z,2017-03-28T13:02:48Z,2017-00094,0,0,09000064824529dd